CVS Health (CVS) Tops Q1 EPS by 6c, Q2 EPS Guidance Tops Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- BofA Securities Reiterates Buy Rating on Apple (AAPL)
- Shipping stocks on fire — but cracks are forming in the rate rally
CVS Health (CVS) PT Raised to $91 at RBC Capital; Technical Issues Weighing on Shares
May 3, 2018 8:39 AM EDTRBC Capital raised its price target on CVS Health (NYSE: CVS) to $91.00 (from $89.00) while maintaining a Outperform rating.
Analyst George Hill commented, "CVS reported Q1 results that beat our estimates and consensus, driven by stronger- than-expected results in the Pharmacy/LTC... More
